Translational Approaches In Cardiovascular Diseases by Omics
Related Experiment Video
Updated: Feb 23, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Vahideh Rabani1, Siamak Davani2
1EA 3920, Univ. Bourgogne-Franche Comté, Besançon, France.
Insights
High-throughput omics analyses offer promising new ways to find biomarkers and therapeutic targets for cardiovascular diseases, aiming to reduce illness and death. These advanced methods provide deep insights into cellular functions for better disease management.
Area of Science:
- Biomedical Research
- Genomics
- Proteomics
- Metabolomics
Background:
- Cardiovascular diseases (CVDs) are a major global health concern, causing significant morbidity and mortality.
- Despite advancements in prediction, diagnostics, and therapy, novel biomarkers and therapeutic targets are crucial for reducing the impact of CVDs.
Purpose of the Study:
- To review the application of high-throughput omics analyses in discovering new biomarkers and therapeutic targets for cardiovascular diseases.
- To highlight the potential of omics technologies in advancing cardiovascular research and clinical practice.
Main Methods:
- Review of current literature on omics technologies (genomics, proteomics, metabolomics, etc.) applied to cardiovascular research.
- Analysis of how these high-throughput methods provide a comprehensive view of cellular and tissue pathways relevant to CVDs.
Main Results:
- Omics approaches have revolutionized biological and medical research, offering unprecedented insights into complex biological systems.
- These methods enable the identification of novel molecular signatures and pathways implicated in cardiovascular pathologies.
- The interdisciplinary nature of omics facilitates a holistic understanding of disease mechanisms.
Conclusions:
- High-throughput omics analyses represent a powerful and promising strategy for identifying new biomarkers and therapeutic targets in cardiovascular diseases.
- Continued research and application of omics technologies are essential for reducing the burden of cardiovascular morbidity and mortality.
Abstract:
Cardiovascular diseases are among the leading causes of morbidity and mortality. Despite scientific and technical progress in risk prediction, diagnostics, prognostication and therapy of cardiovascular pathologies, new biomarkers and therapeutic targets remain the subject of intense research to reduce the burden of these diseases. High throughput analyses, termed "omics", are a promising avenue of research. These recently developed technical fields have revolutionized biological and medical research in a very short time. By their interdisciplinary nature, these new methods have already provided a wide vision of cell and tissue pathways and functions. Here, we review how these methods can help to discover new biomarkers and therapeutic targets in cardiovascular diseases.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Translational Regulation
Genomics
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
